A股異動 | 依米康三連板 公司業務在"東數西算"工程規劃下將面臨機遇與挑戰
格隆匯2月22日丨依米康(300249.SZ)連續三日“20cm”漲停,報14.09元創約5年新高,總市值62億元。依米康昨晚披露股票交易異動公吿,公司目前業務包括信息數據及環保治理兩大領域,其中信息數據領域業務在國家推動“東數西算”工程規劃下將面臨機遇與挑戰。但本次政策的出台對公司業績情況的影響取決於相關業務的推廣運營、成本控制能力等多重因素,公司尚無法準確預測其對公司經營業績的影響情況。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.